Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells.
Watanabe H, Ishibashi K, Mano H, Kitamoto S, Sato N, Hoshiba K, Kato M, Matsuzawa F, Takeuchi Y, Shirai T, Ishikawa S, Morioka Y, Imagawa T, Sakaguchi K, Yonezawa S, Kon S, Fujita Y. Watanabe H, et al. Among authors: matsuzawa f. Cell Rep. 2018 Jun 26;23(13):3721-3729. doi: 10.1016/j.celrep.2018.05.081. Cell Rep. 2018. PMID: 29949757 Free article.
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.
Mizukami T, Kamachi H, Fujii Y, Matsuzawa F, Einama T, Kawamata F, Kobayashi N, Hatanaka Y, Taketomi A. Mizukami T, et al. Among authors: matsuzawa f. Oncotarget. 2018 Sep 18;9(73):33844-33852. doi: 10.18632/oncotarget.26117. eCollection 2018 Sep 18. Oncotarget. 2018. PMID: 30333914 Free PMC article.
Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model.
Fujii Y, Kamachi H, Matsuzawa F, Mizukami T, Kobayashi N, Fukai M, Taketomi A. Fujii Y, et al. Among authors: matsuzawa f. Invest New Drugs. 2021 Oct;39(5):1256-1266. doi: 10.1007/s10637-021-01118-1. Epub 2021 Apr 27. Invest New Drugs. 2021. PMID: 33905019
Clinical impacts of mesothelin expression in gastrointestinal carcinomas.
Einama T, Kawamata F, Kamachi H, Nishihara H, Homma S, Matsuzawa F, Mizukami T, Konishi Y, Tahara M, Kamiyama T, Hino O, Taketomi A, Todo S. Einama T, et al. Among authors: matsuzawa f. World J Gastrointest Pathophysiol. 2016 May 15;7(2):218-22. doi: 10.4291/wjgp.v7.i2.218. World J Gastrointest Pathophysiol. 2016. PMID: 27190694 Free PMC article. Review.
44 results